Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 6:e1814.
doi: 10.1002/wrna.1814. Online ahead of print.

Saccharomyces cerevisiae as a research tool for RNA-mediated human disease

Stephanie Gastelum  1 , Allison F Michael  2 , Timothy A Bolger  2
Affiliations
Review

Saccharomyces cerevisiae as a research tool for RNA-mediated human disease

Stephanie Gastelum et al. Wiley Interdiscip Rev RNA. .

Abstract

The budding yeast, Saccharomyces cerevisiae, has been used for decades as a powerful genetic tool to study a broad spectrum of biological topics. With its ease of use, economic utility, well-studied genome, and a highly conserved proteome across eukaryotes, it has become one of the most used model organisms. Due to these advantages, it has been used to study an array of complex human diseases. From broad, complex pathological conditions such as aging and neurodegenerative disease to newer uses such as SARS-CoV-2, yeast continues to offer new insights into how cellular processes are affected by disease and how affected pathways might be targeted in therapeutic settings. At the same time, the roles of RNA and RNA-based processes have become increasingly prominent in the pathology of many of these same human diseases, and yeast has been utilized to investigate these mechanisms, from aberrant RNA-binding proteins in amyotrophic lateral sclerosis to translation regulation in cancer. Here we review some of the important insights that yeast models have yielded into the molecular pathology of complex, RNA-based human diseases. This article is categorized under: RNA in Disease and Development > RNA in Disease.

Keywords: COVID-19; RNA; aging; neurodegeneration; yeast.

PubMed Disclaimer

References

FURTHER READING
    1. van Leeuwen, F. W., de Kleijn, D. P., van den Hurk, H. H., Neubauer, A., Sonnemans, M. A., Sluijs, J. A., Koycu, S., Ramdjielal, R. D., Salehi, A., Martens, G. J., Grosveld, F. G., Peter, J., Burbach, H., & Hol, E. M. (1998). Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and down patients. Science, 279(5348), 242-247. https://doi.org/10.1126/science.279.5348.242
REFERENCES
    1. Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021). Author correction: Parkinson disease-associated cognitive impairment. Nature Reviews Disease Primers, 7(1), 53. https://doi.org/10.1038/s41572-021-00292-z
    1. Alberti, S., Halfmann, R., King, O., Kapila, A., & Lindquist, S. (2009). A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell, 137(1), 146-158. https://doi.org/10.1016/j.cell.2009.02.044
    1. Almazan, F., Galan, C., & Enjuanes, L. (2008). Engineering infectious cDNAs of coronavirus as bacterial artificial chromosomes. Methods in Molecular Biology, 454, 275-291. https://doi.org/10.1007/978-1-59745-181-9_20
    1. Alzheimer's disease facts and figures. (2020). Alzheimers dement. https://doi.org/10.1002/alz.12068
    1. An, H., Skelt, L., Notaro, A., Highley, J. R., Fox, A. H., La Bella, V., Buchman, V. L., & Shelkovnikova, T. A. (2019). ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathologica Communications, 7(1), 7. https://doi.org/10.1186/s40478-019-0658-x

LinkOut - more resources